Company Filing History:
Years Active: 2008
Title: Elizabeth M Berry-Kravis: Innovator in Genetic Diagnostics
Introduction
Elizabeth M Berry-Kravis is a prominent inventor based in Des Plaines, IL (US). She has made significant contributions to the field of genetic diagnostics, particularly in relation to congenital conditions. Her work has the potential to improve the lives of many individuals affected by rare genetic disorders.
Latest Patents
Elizabeth holds a patent for "Methods and primers for diagnosing idiopathic congenital central hypoventilation syndrome." This invention provides assays and kits designed for the diagnosis of this specific syndrome. The focus of her patent is on the second polyalanine repeat of the PHOX2b gene, which is typically 20 residues in length. Notably, a polyalanine repeat that ranges from 25 to 33 residues is strongly correlated with idiopathic congenital central hypoventilation syndrome. This advancement in diagnostic methods is crucial for early detection and intervention.
Career Highlights
Elizabeth is affiliated with the Chicago Community Foundation, where she applies her expertise in genetics and diagnostics. Her career is marked by a commitment to advancing medical science and improving patient outcomes through innovative research and development.
Collaborations
Elizabeth has collaborated with notable colleagues in her field, including Debra E Weese-Mayer and Lili Zhou. These partnerships have fostered a collaborative environment that enhances research and innovation in genetic diagnostics.
Conclusion
Elizabeth M Berry-Kravis is a trailblazer in the field of genetic diagnostics, with her patent contributing significantly to the understanding and diagnosis of congenital conditions. Her work exemplifies the impact of innovation in medicine and the importance of collaboration in advancing scientific knowledge.